Dogwood Therapeutics's market cap is currently $10.55M. The company's EPS TTM is $-1.99; its P/E ratio is ―; Dogwood Therapeutics is scheduled to report earnings on August 13, 2025, and the estimated EPS forecast is $-1.17. See an overview of income statement, balance sheet, and cash flow financials.
